Open6.800 | Close6.660 |
Vol / Avg.438.656K / 523.967K | Mkt Cap409.080M |
Day Range6.450 - 6.910 | 52 Wk Range3.260 - 14.044 |
Terns Pharma Stock (NASDAQ: TERN) stock price, news, charts, stock research, profile.
Open6.800 | Close6.660 |
Vol / Avg.438.656K / 523.967K | Mkt Cap409.080M |
Day Range6.450 - 6.910 | 52 Wk Range3.260 - 14.044 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.300 | -0.420 | -0.1200 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.340 | -0.250 | 0.0900 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-12-05 | JMP Securities | Silvan Tuerkcan | Reiterates | Market OutperformMarket Outperform | Maintains | - | 17.00 |
2023-11-27 | Mizuho | Graig Suvannavejh | Maintains | BuyBuy | Lowers | 17.00 | 10.00 |
2023-08-10 | HC Wainwright & Co. | Ed Arce | Maintains | NeutralNeutral | Lowers | 11.00 | 8.00 |
2023-08-09 | JP Morgan | Eric Joseph | Maintains | NeutralNeutral | Raises | 10.00 | 11.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
TERN | Terns Pharma | -2.79% | 409.1M |
AVIR | Atea Pharmaceuticals | 2.04% | 250.3M |
TBPH | Theravance Biopharma | 1.23% | 534.3M |
THRD | Third Harmonic Bio | 2.01% | 388.7M |
GHRS | GH Research | 9% | 340.2M |
You can purchase shares of Terns Pharma (NASDAQ: TERN) through any online brokerage.
Other companies in Terns Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
The latest price target for Terns Pharma (NASDAQ: TERN) was reported by JMP Securities on Tuesday, December 5, 2023. The analyst firm set a price target for 17.00 expecting TERN to rise to within 12 months (a possible 156.80% upside). 24 analyst firms have reported ratings in the last year.
The stock price for Terns Pharma (NASDAQ: TERN) is $6.62 last updated December 8, 2023 at 9:46 PM UTC.
There is no dividend information for Terns Pharma.
Terns Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
There is no upcoming split for Terns Pharma.
Terns Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.